Synapse - Kristin Fallon-Hanley

Kristin Fallon-Hanley

Research Focus

Former Employee. COLLABORATIVE RESEARCH CENTERS - PIC DIRECTED; NE Affiliate

Recent additions – View all

A phase II study of intravenous (IV) and intraperitoneal (IP) paclitaxel (Tax), IP cisplatin (Cis), and IV bevacizumab (Bev) as first-line chemotherapy for optimal stage II or III ovarian, primary peritoneal, and fallopian tube cancer
Meeting Abstract

Konner, J. A.; Fallon, K.; Pezzuli, S.; Iasonos, A.; Sabbatini, P.; Hensley, M.; Chiang, A.; Tew, W.; Spriggs, D.; Aghajanian, C.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

Co-authors at MSK

1

Aghajanian
1

Chiang
1

Hensley
1

Iasonos
1

Konner
1

Pezzulli
1

Sabbatini
1

Spriggs
1

Tew

Types of Work

Publications

Journal of Clinical Oncology (1)